Role of mammography screening as a predictor of survival in postmenopausal breast cancer patients

British Journal of Cancer

Volumn 94, Issue 1, 2006, Pages 147-151

  Anttinen, J ^a   Kautiainen, H ^b   Kuopio, T ^a  

^a JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^b Medcare Foundation   (Finland)

Author keywords

Breast cancer screening; Breast cancer survival; Screening as independent prognostic factor

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTIVARIATE ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; SCREENING TEST; TUMOR VOLUME;

AGED; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 30644473944     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602895     Document Type: Article

References (25)

1. Anttinen J, Kuopio T, Nykänen M, Torkkeli H, Saari U, Juhola M (2003) Her-2/Neu oncogene amplification and protein over-expression in interval and screen detected breast Cancers. Anticancer Res 23: 4213-4421
2. Brekelmans CT, Peeters PH, Deurenberg JJ, Collette HJ (1995) Survival in interval breast cancer in the DOM screening programme. Eur J Cancer 31A: 1830-1835
3. Burrell HC, Sibbering DM, Wilson ARM, Pinder SE, Evans AJ, Lindsey JY, Elston CW, Ellis IO, Blamey RW, Robertson JFR (1996) Screening interval breast cancers: mammographic features and prognostic factors. Radiology 199: 811-817
4. Crosier M, Scott D, Wilson RG, Griffith CDM, May FEB, Wesley BE (1999) Differences in Ki-67 and c-erbB2 expression between screen detected and true interval breast cancers. Clin Cancer Res 5: 2682-2688
5. Duffy SW, Tabar L, Chen H-H, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C, Sundbom A, Tholin M, Wiege M, Akerlund A, Wu HM, Tung TS, Chiu YH, Chiu CP, Huang CC, Smith RA, Rosen M, Stenbeck M, Holmberg M (2002) The impact of organised mammography service screening on breast cancer mortality in seven Swedish counties. A collaborative evaluation. Cancer 95: 458-469
6. Ernst MF, Voogd AC, Coebergh JW, Roukeme JA (2004) Breast carcinoma diagnosis, treatment and prognosis before and after the introduction of mass mammographic screening. Cancer 100: 1337-1344
7. Everington D, Gilbert FJ, Tyack C, Warner J (1999) The Scottish screening programme's experience of monitoring interval cancers. J Med Screen 6: 21-27
8. Fracheboud J, Otto SJ, vanDijk JAAM, Broeders MJM, Verbeek ALM, deKoonig HJ (2004) Decreasing rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer 91: 861-867
9. Gill PG, Farshid G, Luke CG, Roder DM (2004) Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancer. The Breast 13: 15-22
10. Gilliland FD, Joste N, Stauber PM, Hunt WC, Rosenberg R, Redlich G, Key CR (2000) Biologic characteristics of interval and screen detected carcinomas. J Natl Cancer Inst 92: 743-749
11. Gorini G, Zappa M, Miccinesi G, Paci E, Costantini AS (2004) Breast cancer mortality trends in two areas of province of Florence, Italy, where screening programs started in the 1970s and 1990s. Br J Cancer 90: 1780-1783
12. Gotzsche PC, Olsen O (2000) Is screening for breast cancer with mammography justifiable?. Lancet 355: 129-134
13. Groenendijk RB, Bult P, Noppen CM, Boetes C, Ruers TJ, Wobbes T (2003) Mitotic acticity index in interval cancers. Eur J Surg Oncol 29: 29-31
14. Hakama M, Elovainio L, Kajantie R, Louhivuori K (1991) Breast cancer screening as public health policy in Finland. Br J Cancer 64: 962-964
15. IARC (2002) Mammography screening can reduce deaths from breast cancer. Press Release, 139, Volume 2003. Lyon: IARC Press
16. Joensuu H, Lehtimäki T, Holli K, Elomaa L, Turpeenniemi-Hujanen T, Kataja V, Anttila A, Lundin M, Isola J, Lundin J (2004) Risk for distant recurrence of breast cancer detected by mammography screening or other method. JAMA 292: 1064-1073
17. Klemi PJ, Parvinen I, Pylkkänen L, Kauhava L, Immonen- Räihä P, Räsänen O, Helenius H (2003) Significant improvement in breast cancer survival trough population-based mammography screening. The Breast 12: 308-313
18. Kricker A, Farac K, Smith D, Sweeny A, McCredie M, Armstrong BK (1999) Breast cancer in New South Wales in 1972-1992: tumor size and the impact of mammographic screening. Int J Cancer 81: 877-880
19. McCann J, Stockton D, Day N (1998) Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis. J Med Sreen 5: 42-48
20. Paci E, Duffy SW, Giorgi D, Zappa M, Crocetti E, Bianchi S, Rosselli del Turco M (2002) Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. Br J Cancer 87: 65-69
21. Peeters PHM, Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Vooijs GP (1989) The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer 59: 929-932
22. Porter PL, El-Bastwissi AY, Mandelson MT, Lin MG, Khalid N, Watney AE, Cousens L, White D, Taplin S, White E (1999) Breast tumour characteristics as predictors of mammographic detection: comparision of interval- and screen detected cancers. J Natl Cancer Inst 91: 2020-2028
23. Shapiro S, Coleman EA, Broeders M, Cood M, deKoonig H, Frachboud J, Moss S, Paci E, Stachenko E, Ballard-Barbash R (1998) Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. Int J Epid 27: 735-742
24. Sobin LH, Witekind C (eds) (2002) UICC TNM Classification of Malignant Tumours. 6th ed. New-York: Wiley-Liss 2002
25. Tabar L, Yen MF, Vitak B, Chen H-H, Smith RT, Duffy SW (2003) Mammography service screening and mortality in breast cancer patients: 20-years follow-up before and after the introduction of screening. Lancet 361: 1405-1410